Allergen immunotherapy: A long-term perspective

R. Patterson; L. C. Grammer

doi:10.1016/S1081-1206(10)63280-2

Allergen immunotherapy: A long-term perspective

R. Patterson^*, L. C. Grammer

^*Corresponding author for this work

Medicine, Allergy Division

Research output: Contribution to journal › Editorial › peer-review

6 Scopus citations

Abstract

Efficacy of standard IT to reduce medications and symptoms by at least 50% has been demonstrated multiple times. Reports of negative studies of IT deserve only evaluation of why the study design failed to demonstrate efficacy. Emphasis in the US and worldwide should be on education on the appropriate use of allergen IT, improvements in IT therapy, and preparation for the increased demand for allergists-immunologists as Fellowship training programs decline in numbers and individual training slots decrease.

Original language	English (US)
Pages (from-to)	315-316
Number of pages	2
Journal	Annals of Allergy, Asthma and Immunology
Volume	82
Issue number	4
DOIs	https://doi.org/10.1016/S1081-1206(10)63280-2
State	Published - 1999

Funding

Supported by the Ernest S. Bazley Grant to Northwestern Memorial Hospital and North-western University Medical School, Chicago, Illinois.

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Immunology and Allergy
Immunology

Access to Document

10.1016/S1081-1206(10)63280-2

Cite this

@article{269b0f3fd45c4f98b1f2b4c5ac075e78,

title = "Allergen immunotherapy: A long-term perspective",

abstract = "Efficacy of standard IT to reduce medications and symptoms by at least 50% has been demonstrated multiple times. Reports of negative studies of IT deserve only evaluation of why the study design failed to demonstrate efficacy. Emphasis in the US and worldwide should be on education on the appropriate use of allergen IT, improvements in IT therapy, and preparation for the increased demand for allergists-immunologists as Fellowship training programs decline in numbers and individual training slots decrease.",

author = "R. Patterson and Grammer, {L. C.}",

note = "Funding Information: Supported by the Ernest S. Bazley Grant to Northwestern Memorial Hospital and North-western University Medical School, Chicago, Illinois.",

year = "1999",

doi = "10.1016/S1081-1206(10)63280-2",

language = "English (US)",

volume = "82",

pages = "315--316",

journal = "Annals of Allergy, Asthma and Immunology",

issn = "1081-1206",

publisher = "American College of Allergy, Asthma and Immunology",

number = "4",

}

TY - JOUR

T1 - Allergen immunotherapy

T2 - A long-term perspective

AU - Patterson, R.

AU - Grammer, L. C.

N1 - Funding Information: Supported by the Ernest S. Bazley Grant to Northwestern Memorial Hospital and North-western University Medical School, Chicago, Illinois.

PY - 1999

Y1 - 1999

N2 - Efficacy of standard IT to reduce medications and symptoms by at least 50% has been demonstrated multiple times. Reports of negative studies of IT deserve only evaluation of why the study design failed to demonstrate efficacy. Emphasis in the US and worldwide should be on education on the appropriate use of allergen IT, improvements in IT therapy, and preparation for the increased demand for allergists-immunologists as Fellowship training programs decline in numbers and individual training slots decrease.

AB - Efficacy of standard IT to reduce medications and symptoms by at least 50% has been demonstrated multiple times. Reports of negative studies of IT deserve only evaluation of why the study design failed to demonstrate efficacy. Emphasis in the US and worldwide should be on education on the appropriate use of allergen IT, improvements in IT therapy, and preparation for the increased demand for allergists-immunologists as Fellowship training programs decline in numbers and individual training slots decrease.

UR - http://www.scopus.com/inward/record.url?scp=0032929969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032929969&partnerID=8YFLogxK

U2 - 10.1016/S1081-1206(10)63280-2

DO - 10.1016/S1081-1206(10)63280-2

M3 - Editorial

C2 - 10227330

AN - SCOPUS:0032929969

SN - 1081-1206

VL - 82

SP - 315

EP - 316

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

IS - 4

ER -

Allergen immunotherapy: A long-term perspective

Abstract

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this